BioSNARKs by litegravlitegrav develops tools for a new and decentralized biotech era, inspired by space tech. Space-like conditions allow to develop previously unseen therapeutics and materials, however costs and complexity are still limiting factors. litegrav solves this by providing novel protocols and hardware for rapid acceleration in biotech, whether it is for Earth or space.Initially developed for immutable reproducibility of complex experiments, BioSNARKs will function as a data access platform to accelerate drug and biotech development by allowing IP-safe utilization of data between stakeholders in the field. This is especially important for rare disease treatment discoveries, where data silos can be killers.
• Alumni of European Space Agency Business Incubator
• BioSNARKs empowers the $10bn preclinical market to “rent” their data for drug optimization, allowing e.g. big pharma to re-monetize unused and negative findings
• Non-interactive zero knowledge proofs for absolute privacy preserve
• Team with multiple PhDs in biology, cryptography/mathematics, machine learning combined with biopharma and DeSci expertise
• 10+ university and industrial partners to leverage the scaling
Currently they are raising their seed round to ramp up partnerships and expand to the US biotech market to offer new ways for rapid collaboration and validation of experiments.